Health-related quality of life and symptom management research sponsored by the national cancer institute

Journal of Clinical Oncology

Volumn 25, Issue 32, 2007, Pages 5128-5132

  Minasian, Lori M ^a   O'Mara, Ann M ^a   Reeve, Bryce B ^a   Denicoff, Andrea M ^a   Kelaghan, Joseph ^a   Rowland, Julia H ^a   Trimble, Edward L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANOREXIA; BREAST CANCER; CANCER DIAGNOSIS; CANCER RESEARCH; CANCER SURVIVAL; CANCER THERAPY; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE DEFECT; COLORECTAL CANCER; CONFERENCE PAPER; DISTRESS SYNDROME; DYSPNEA; ENDOCRINE FUNCTION; FATIGUE; GYNECOLOGIC CANCER; HEAD AND NECK CANCER; HEALTH CARE ORGANIZATION; HUMAN; LUNG CANCER; LYMPHEDEMA; MELANOMA; MUCOSA INFLAMMATION; NAUSEA AND VOMITING; PAIN; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; SARCOMA; SEXUAL FUNCTION; SLEEP DISORDER; WEIGHT GAIN; WEIGHT REDUCTION;

CLINICAL TRIALS AS TOPIC; HUMANS; NATIONAL CANCER INSTITUTE (U.S.); NEOPLASMS; PATIENT SATISFACTION; PROFESSIONAL STAFF COMMITTEES; QUALITY INDICATORS, HEALTH CARE; QUALITY OF LIFE; SICKNESS IMPACT PROFILE; TREATMENT OUTCOME; UNITED STATES;

EID: 36849081241     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.12.6672     Document Type: Conference Paper

References (14)

1. National Institutes of Health Consensus Development Program: Symptom management in cancer: Pain, depression, and fatigue. http://consensus.nih.gov/ 2002/2002CancerPainDepressionFatiguesos022main.htm
2. Dahl JL: Pain: Impediments and suggestions for solutions. J Natl Cancer Inst Monogr 32:124-126, 2004
3. Goldberg GR, Morrison RS: Pain management in hospitalized cancer patients: A systematic review. J Clin Oncol 25:1792-1801, 2007
4. Nayfield SG, Hailey BJ, McCabe M: Quality of life assessment in cancer clinical trials: Report of the Workshop on Quality of Life Research in Cancer Clinical Trials, July 16-17, 1990. Bethesda, MD, US Department of Health and Human Services, 1991
5. Varricchio CG, McCabe MS, Trimble E, et al: Quality of life in clinical cancer trials. J Natl Cancer Inst Monogr 20:1-116, 1996
6. Lipscomb J, Gotay CC, Snyder C: Outcomes Assessment in Cancer: Measures, Methods, and Applications. Cambridge, United Kingdom, Cambridge University Press, 2005
7. McCabe MS: A cooperative group report on quality-of-life research: Lessons learned. J Natl Cancer Inst Monogr 20:63-65, 1996
8. Watkins-Bruner D, Scott C, Lawton C, et al: RTOG's first quality of life study-RTOG 90-20: A phase II trial of external beam radiation with etanidazole for locally advanced prostate cancer. Int J Radiat Oncol Biol Phys 33:901-906, 1995
9. Armstrong DK, Bundy B, Wenzel L, et al: Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 354:34-43, 2006
10. Wenzel LB, Huang HQ, Armstrong DK, et al: Health-related quality of life during and after intraperitoneal versus intravenous chemotherapy for optimally debulked ovarian cancer: A Gynecologic Oncology Group study. J Clin Oncol 25:437-443, 2007
11. Buchanan DR, O'Mara AM, Kelaghan JW, et al: Quality-of-life assessment in the symptom management trials of the National Cancer Institute-supported Community Clinical Oncology Program. J Clin Oncol 23:591-598, 2005
12. Therasse P, Arbuck SG, Eisenhauer EA, et al: New guidelines to evaluate the response to treatment in solid tumors: European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205-216, 2000
13. Doroshow JH, Fine HA, Abbruzzese JL, et al: Restructuring the National Cancer Clinical Trials Enterprise: Report of the Clinical Trials Working Group of the National Cancer Advisory Board. Bethesda, MD, National Cancer Institute, 2005. http://integratedtrials.nci.nih.gov/ict/CTWG_report_June2005.pdf
14. US Food and Drug Administration: Guidance for industry on patient-reported outcome measures: Use in medical products development to support labeling claims. February, 2006. http://www.fda.gov/OHRMS/DOCKETS/98fr/ 06d-0044-gdl0001.pdf